Classical risk factors for primary coronary artery disease from an aging perspective through Mendelian Randomization

[1]  R. Mägi,et al.  Stratification of Type 2 Diabetes by Age of Diagnosis in the UK Biobank Reveals Subgroup-Specific Genetic Associations and Causal Risk Profiles , 2021, Diabetes.

[2]  J. C. Christiansen,et al.  Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study. , 2020, Annals of internal medicine.

[3]  J. Gussekloo,et al.  Recommendations for (Discontinuation of) Statin Treatment in Older Adults: Review of Guidelines , 2019, Journal of the American Geriatrics Society.

[4]  R. Giugliano,et al.  Association Between Triglyceride Lowering and Reduction of Cardiovascular Risk Across Multiple Lipid-Lowering Therapeutic Classes: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials. , 2019, Circulation.

[5]  S. le Cessie,et al.  Survival Bias in Mendelian Randomization Studies , 2019, Epidemiology.

[6]  K. Rahimi,et al.  Systolic Blood Pressure and Risk of Valvular Heart Disease: A Mendelian Randomization Study. , 2019, JAMA cardiology.

[7]  M. Murad,et al.  Antihypertensive Agents in Older Adults: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. , 2019, The Journal of clinical endocrinology and metabolism.

[8]  John Fuller,et al.  Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials , 2019, The Lancet.

[9]  Samy I McFarlane,et al.  Cardiovascular Risk Reduction Associated with Pharmacological Weight Loss: A Meta-Analysis. , 2019, International journal of clinical research & trials.

[10]  M. McCarthy,et al.  Association of Genetically Enhanced Lipoprotein Lipase–Mediated Lipolysis and Low-Density Lipoprotein Cholesterol–Lowering Alleles With Risk of Coronary Disease and Type 2 Diabetes , 2018, JAMA cardiology.

[11]  G. Davey Smith,et al.  Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians , 2018, British Medical Journal.

[12]  A. Avenell,et al.  Effects of weight loss interventions for adults who are obese on mortality, cardiovascular disease, and cancer: systematic review and meta-analysis , 2017, British Medical Journal.

[13]  Tom R. Gaunt,et al.  Causal Associations of Adiposity and Body Fat Distribution With Coronary Heart Disease, Stroke Subtypes, and Type 2 Diabetes Mellitus: A Mendelian Randomization Analysis , 2017, Circulation.

[14]  S. Anderson,et al.  Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis , 2016, The Lancet.

[15]  Andres Metspalu,et al.  The transcriptional landscape of age in human peripheral blood , 2015, Nature Communications.

[16]  Gabor T. Marth,et al.  A global reference for human genetic variation , 2015, Nature.

[17]  Tom R. Gaunt,et al.  The UK10K project identifies rare variants in health and disease , 2015, Nature.

[18]  Barry J. Davis,et al.  Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials , 2015, The Lancet.

[19]  P. Elliott,et al.  UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.

[20]  Ross M. Fraser,et al.  Genetic studies of body mass index yield new insights for obesity biology , 2015, Nature.

[21]  Hermann Brenner,et al.  Cross-sectional and longitudinal changes in DNA methylation with age: an epigenome-wide analysis revealing over 60 novel age-associated CpG sites. , 2014, Human molecular genetics.

[22]  Tanya M. Teslovich,et al.  Discovery and refinement of loci associated with lipid levels , 2013, Nature Genetics.

[23]  P. Rabinovitch,et al.  Cardiac aging: from molecular mechanisms to significance in human health and disease. , 2012, Antioxidants & redox signaling.

[24]  David A Sinclair,et al.  The intersection between aging and cardiovascular disease. , 2012, Circulation research.

[25]  David M. W. Powers,et al.  Evaluation: from precision, recall and F-measure to ROC, informedness, markedness and correlation , 2011, ArXiv.

[26]  Tom R. Gaunt,et al.  Genetic Variants in Novel Pathways Influence Blood Pressure and Cardiovascular Disease Risk , 2011, Nature.

[27]  Gaël Varoquaux,et al.  Scikit-learn: Machine Learning in Python , 2011, J. Mach. Learn. Res..

[28]  Michael J. Pencina,et al.  Arterial Stiffness and Cardiovascular Events: The Framingham Heart Study , 2010, Circulation.

[29]  René S. Kahn,et al.  The Relationship of DNA Methylation with Age, Gender and Genotype in Twins and Healthy Controls , 2009, PloS one.

[30]  Chih-Jen Lin,et al.  LIBLINEAR: A Library for Large Linear Classification , 2008, J. Mach. Learn. Res..

[31]  Li-sheng Liu,et al.  Treatment of hypertension in patients 80 years of age or older. , 2008, The New England journal of medicine.

[32]  R. Collins,et al.  Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths , 2007, The Lancet.

[33]  S. Yusuf,et al.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.

[34]  P. Macfarlane,et al.  Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial , 2002, The Lancet.

[35]  A. Hofman,et al.  Blood pressure and risk of myocardial infarction in elderly men and women: the Rotterdam study. , 1999, Journal of hypertension.

[36]  Karla Kerlikowske,et al.  Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials , 1999, The Lancet.

[37]  A. D. de Craen,et al.  Evidence-based medicine in older patients: how can we do better? , 2015, The Netherlands journal of medicine.

[38]  Ian C. Marschner,et al.  glm2: Fitting Generalized Linear Models with Convergence Problems , 2011, R J..

[39]  George Davey Smith,et al.  Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology , 2008, Statistics in medicine.

[40]  Edinburgh Research Explorer Mendelian randomization of blood lipids for coronary heart disease , 2022 .